Emily Dressler to Sirolimus
This is a "connection" page, showing publications Emily Dressler has written about Sirolimus.
Connection Strength
0.227
-
Massarweh S, Romond E, Black EP, Van Meter E, Shelton B, Kadamyan-Melkumian V, Stevens M, Elledge R. A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure. Breast Cancer Res Treat. 2014 Jan; 143(2):325-32.
Score: 0.227